Clinical Trials Logo

Dyspepsia clinical trials

View clinical trials related to Dyspepsia.

Filter by:

NCT ID: NCT01677715 Completed - Constipation Clinical Trials

Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System

Start date: August 2011
Phase: N/A
Study type: Interventional

Study on Evaluating the Promote Effect of Yili Mei Yi Tian Active Lactobacillus Drink on Immunity and Physical Intestinal Canal

NCT ID: NCT01671670 Completed - Clinical trials for Functional Dyspepsia

Acupuncture for Patients With Function Dyspepsia

Start date: September 2012
Phase: Phase 2/Phase 3
Study type: Interventional

Hypothesis: Acupuncture is efficacious and safe for patients with functional dyspepsia Design: - A single blind randomized controlled trial - 200 participants will be included - Two arms: acupuncture and sham acupuncture group

NCT ID: NCT01670552 Completed - Dyspepsia Clinical Trials

Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients

Start date: February 17, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety of an association with one anti-inflammatory and one gastroprotective agent compared to the one anti-inflammatory and one gastroprotective agent in patients with acute or chronic osteoarticular inflammation.

NCT ID: NCT01667692 Completed - Dyspepsia Clinical Trials

Aizthromycin or Clarithromycin in H-pylori Eradication Regimen

H-pylori
Start date: March 2011
Phase: Phase 4
Study type: Interventional

The Aim of this study is comparison between two regimens containing clarithromycinand azithromycin.

NCT ID: NCT01643083 Completed - Clinical trials for Functional Dyspepsia

Rifaximin for Functional Dyspepsia

Start date: January 2013
Phase: Phase 2/Phase 3
Study type: Interventional

Functional dyspepsia is a very common medical condition, which occurs in up to 30% of people in the community. However, results of current pharmacological treatment on functional dyspepsia are unsatisfactory. Rifaximin is a minimally absorbed antibiotic that has been used in treatment of non-constipated irritable bowel syndrome (IBS). In particular, bloating and abdominal pain was improved by rifaximin treatment in this group of IBS patients. Whilst there is considerable overlap in symptoms of functional dyspepsia and IBS, the investigators test whether rifaximin is also effective in curing post-prandial distress symptoms related to dyspepsia.

NCT ID: NCT01608750 Not yet recruiting - Nonulcer Dyspepsia Clinical Trials

The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia

Start date: June 2012
Phase: Phase 4
Study type: Interventional

The aim of our study is to evaluate the effectiveness of proton pump inhibitor (PPI) treatment in patients with functional dyspepsia.

NCT ID: NCT01591174 Completed - Clinical trials for Functional Dyspepsia

Ghrelin and Gastric Emptying in Children With Functional Dyspepsia

GHR
Start date: May 2012
Phase:
Study type: Observational

The purpose of this research is to see if there are differences between children who have FD and children without FD in the ability of the stomach to empty food and/or in ghrelin hormone levels before and after eating. Chronic abdominal pain is the most common persistent pain condition in children and adolescents. One of the most often diagnosed types of abdominal pain is functional dyspepsia (FD). FD is abdominal pain or discomfort (e.g., nausea, bloating) in the upper abdomen that does not get better by having a bowel movement. One possible explanation for having FD is a delay in the emptying of food from the stomach, or delayed gastric (stomach) emptying. Failing to empty the stomach quickly enough may result in the feeling of being full and cause symptoms of bloating, nausea, vomiting and pain. Further, hormonal changes occur before, during, or after eating food that appear to impact stomach emptying. One of the hormones that changes with meals is called ghrelin. The relationship between ghrelin and stomach emptying needs to be explored more in children with FD. Better understanding of what causes FD symptoms may help us to improve treatment for this condition.

NCT ID: NCT01456273 Recruiting - Clinical trials for Functional Dyspepsia

From the Biomedical to the Biopsychosocial Model, From Theory to Practice

Start date: March 2009
Phase: N/A
Study type: Interventional

This study aims to evaluate, in patients with functional dyspepsia, a model example of medical care based upon the biopsychosocial model (called: the therapeutic encounter) compared with standard medical care based upon the biomedical model (called: medical consultation).

NCT ID: NCT01449500 Not yet recruiting - Dyspepsia Clinical Trials

Supplementation With L. Reuteri in H. Pylori Infected Adults

Start date: October 2011
Phase: N/A
Study type: Interventional

To determine whether simultaneous use of L. reuteri ProGastria and proton pump inhibitors can eradicate H. pylori in humans in the absence of antibiotics.

NCT ID: NCT01408849 Terminated - Dyspepsia Clinical Trials

Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

Start date: February 2015
Phase: Phase 2
Study type: Interventional

This study aims to evaluate the therapeutic effect of the infusion of Maytenus ilicifolia Mart. ex Reiss leaves, used for 8 weeks, on patients with dyspepsia. Primary endpoint is SODA score, secondary endpoint is endoscopic classification (Sydney).